BPC-157 vs PEG-MGF
The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.
A supercharged version of your muscle's natural repair signal—PEGylated Mechano Growth Factor stays active for days instead of minutes, waking up dormant stem cells to rebuild and strengthen damaged muscle tissue.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
BPC-157
250–500 mcg
PEG-MGF
200–400 mcg
Frequency
BPC-157
Once daily
PEG-MGF
Twice weekly
Administration
BPC-157
Subcutaneous injection
PEG-MGF
Subcutaneous injection
Cycle length
BPC-157
4-6 weeks
PEG-MGF
4-6 weeks
Onset speed
BPC-157
Moderate (1-2 weeks)
PEG-MGF
Moderate (1-2 weeks)
Evidence level
BPC-157
Strong preclinical (extensive animal studies)
PEG-MGF
Strong preclinical (extensive animal studies)
Benefit ratings
Primary Benefit
Secondary Benefit
Additional Benefit
Muscle Recovery
Stem Cell Activation
Tissue Healing
Compound specifications
BPC-157
Molecular formula
C62H98N16O22
Molecular weight
1419.53 g/mol
Half-life
4-6 hours
Bioavailability
~100% (subcutaneous)
CAS number
137525-51-0
PEG-MGF
Molecular formula
C121H200N42O39 (peptide core)
Molecular weight
2867.2 g/mol (peptide) + PEG moiety
Half-life
48-72 hours (vs. minutes for unmodified MGF)
Bioavailability
High when injected subcutaneously or intramuscularly; PEGylation protects from rapid degradation
CAS number
108174-48-7
Dosing compared
BPC-157
Subcutaneous
250 mcg
Once daily · 1-2 weeks
A common starting amount in research practice, often injected near the injured area. BPC-157 has no human dose-finding trials, so doses come from animal studies and documented practice [1][2].
250-500 mcg
Twice daily · 4-6 weeks
Commonly used range for tissue and tendon recovery in research practice [1][3].
500 mcg
Twice daily · 6-8 weeks
Upper end used in practice for more demanding acute injuries [1][3].
PEG-MGF
Subcutaneous
200 mcg
2-3x per week, post-workout · 5-6 week cycle
Lower end of reported community practice [6]. Important: PEG-MGF is a research peptide with no human clinical trials - all dosing is extrapolated from animal data and self-reported use, not established medicine [1][2]. Pegylation extends its half-life versus native MGF.
200-400 mcg
2-3x per week, post-workout · 5-6 week cycle, then time off
Typical reported research-use range, injected near the trained muscle or into abdominal fat shortly after training [6]. This is community practice, not a clinically validated dose; preclinical work shows MGF activates muscle satellite/progenitor cells [1][2].
Best suited for
BPC-157
Tendon and ligament injuries
Sprains, strains, tears, tendinitis - BPC-157 accelerates collagen synthesis and tissue repair [1][7]
Gut healing
IBS, leaky gut, ulcers, inflammatory bowel conditions [1][11] - derived from gastric juice, it has a natural affinity for digestive tissue [3][5]
Muscle injuries
Strains, post-workout recovery, chronic muscle issues - promotes angiogenesis and growth factor expression [8]
Joint problems
Arthritis support, joint pain, cartilage issues - anti-inflammatory and regenerative properties [9][10]
Post-surgical recovery
Accelerating healing after procedures - works systemically to enhance the body's repair mechanisms [2]
PEG-MGF
Athletes Recovering from Muscle Injuries
If you've pulled, strained, or torn a muscle, PEG-MGF could be a game-changer. It activates the satellite cells (muscle stem cells) that your body uses to repair damaged fibers, potentially speeding up your return to training.
Serious Lifters and Bodybuilders
Heavy training creates microdamage in your muscles—that's actually how they grow. PEG-MGF amplifies your body's repair response, potentially helping you recover faster between sessions and make more gains from each workout.
Older Adults Concerned About Muscle Loss
As we age, our muscles become less responsive to the 'repair and grow' signals. Research shows older adults don't produce as much MGF after exercise. Supplementing with PEG-MGF might help restore some of that youthful repair capacity.
Post-Surgical Recovery (Under Medical Supervision)
If you're recovering from surgery involving muscle tissue, PEG-MGF's ability to recruit stem cells and promote tissue repair could support faster healing. Always use under medical guidance in these situations.
Side effects
BPC-157
Common
- Injection site redness
- Mild nausea
- Dizziness
Uncommon
- Headache
- Fatigue
- Hot/cold sensations
Serious
- Allergic reaction
PEG-MGF
Common
- Injection site irritation
- Mild headache
- Temporary fatigue
Uncommon
- Localized swelling
- Blood sugar fluctuations
Serious
- Allergic reaction
Safety & evidence
BPC-157
Evidence level
Strong preclinical (extensive animal studies)
FDA status
Research compound
Safety overview
BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. [5] No FDA approval exists. [4][6] Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. [4][5] Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. [2][4] The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds. [6][7] Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.
Contraindications
- Pregnancy
- Breastfeeding
- Active cancer
- History of cancer
PEG-MGF
Evidence level
Strong preclinical (extensive animal studies)
FDA status
Research compound
Safety overview
PEG-MGF (pegylated mechano growth factor) demonstrates good tolerability in preclinical studies with minimal immunogenicity from pegylation modifications. Intramuscular administration shows local tissue responses consistent with growth factor activity. No serious systemic adverse events in animal models at therapeutic doses. Pegylation extends half-life from 2 hours (native IGF-1 Ec) to 24+ hours, reducing injection frequency while maintaining safety profile similar to parent peptide.
Contraindications
- Active cancer or history of cancer
- Pregnancy or breastfeeding
- Known allergy to peptide components or PEG
- Children and adolescents
- Uncontrolled diabetes
Which is right for you?
Choose BPC-157 if...
- Injury recovery
- Post-surgery healing
- Chronic pain management
- Gut health
Choose PEG-MGF if...
- Muscle injury recovery
- Post-workout muscle repair
- Combating muscle wasting
- Supporting bone healing